Showing results (1111-1120 of 1,376) with videos related to

Sort By:
Pageof 138
Contemporary Clinical Trials Communications|March 20, 2020
Barriers and solutions to implementing a pragmatic diabetes education trial in rural primary care clinicsKristie B Hadden, Connie L Arnold, Laura M Curtis, et al.
The New England Journal of Medicine|September 21, 2012
Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosisRalf Gold, Ludwig Kappos, Douglas L Arnold, et al.
Journal of Magnetic Resonance Imaging : JMRI|September 6, 2024
Longitudinal Multiparametric Quantitative MRI Evaluation of Acute and Chronic Multiple Sclerosis Paramagnetic Rim LesionsAhmed M Elkady, Colm Elliott, Dumitru Fetco, et al.
Journal of Neuroimmunology|September 20, 2006
Neurodegeneration and neuroprotection in multiple sclerosis and other neurodegenerative diseasesSuhayl Dhib-Jalbut, Douglas L Arnold, Don W Cleveland, et al.
JAMA Network Open|October 13, 2021
Comparison of Spinal Cord Magnetic Resonance Imaging Features Among Children With Acquired Demyelinating SyndromesGiulia Fadda, Cesar A Alves, Julia O'Mahony, et al.
Neuroimage|August 30, 2005
Axonal injury in the cerebral normal-appearing white matter of patients with multiple sclerosis is related to concurrent demyelination in lesions but not to concurrent demyelination in normal-appearing white matterSridar Narayanan, Simon J Francis, John G Sled, et al.
Scientific Reports|April 29, 2025
Prostate microcalcification crystallography as a marker of pathologySarah B Gosling, Emily L Arnold, Lois Adams, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|March 10, 2026
Quantitative Choroid Plexus Gadolinium Enhancement Is Related to Diffuse Brain Tissue Injury in Multiple SclerosisSneha Senthil, Ian Tagge, Dumitru Fetco, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|April 12, 2007
Rodent carcinogenicity profile of the antidiabetic dual PPAR alpha and gamma agonist muraglitazarSarah H Tannehill-Gregg, Thomas P Sanderson, Daniel Minnema, et al.
Toxicology and Applied Pharmacology|March 17, 2009
Effects of the PPARgamma agonist troglitazone on endothelial cells in vivo and in vitro: differences between human and mouseSatoko Kakiuchi-Kiyota, Joseph A Vetro, Shugo Suzuki, et al.
Pageof 138